- Kimberly-Clark Corp KMB reported fourth-quarter FY22 sales flat at $4.96 billion, missing the consensus of $4.98 billion.
- Organic sales increased by 5% as net selling prices rose approximately 10%, and product mix increased sales by 1%, while volumes declined by 7%.
- In North America, organic sales rose 1% in consumer products and 18% in K-C Professional.
- Sales from the personal care segment decreased 3%, the consumer tissue segment remained flat, and K-C Professional climbed 11%.
- Adjusted EPS of $1.54 beat the analyst consensus of $1.51.
- Gross profit grew by 13% Y/Y to $1.62 billion. Marketing, research, and general expenses increased 1% Y/Y to $916 million.
- Operating income increased 36.6% to $712 million, with an operating margin of 14.4%.
- Cash provided by operations in the quarter was $991 million. The company held $427 million in cash and equivalents as of Dec. 31, 2022.
- The Board of Directors approved increasing the dividend by 1.7% to $1.18 per share, up from $1.16 per share in 2022. The first dividend will be payable on Apr. 4, 2023, to stockholders of record on Mar. 10, 2023.
- Outlook: Kimberly-Clark expects FY23 sales to increase 0% - 2%. The company sees FY23 EPS to increase 2% - 6% versus FY22 adj EPS.
- It sees capital spending of $800 million - $900 million and share repurchases of $100 million - $150 million, subject to market conditions.
- Price Action: KMB shares are trading lower by 5.31% at $127.48 in premarket on the last check Wednesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in